Research on the mechanism of Sancao Baogan decoction in treating hepatocellular carcinoma based on network pharmacology and molecular docking
Network pharmacology and molecular docking technology were used to study the material basis and possible mecha-nism of Sancao Baogan decoction(SBD)in treatment of hepatocellular carcinoma(HCC).TCMSP database and reports were used to obtain the ingredients of SBD.TCMSP,Swiss target prediction,GeneCards,and OMIM databases were used to obtain drug and HCC related disease targets.R language statistics resulted in the intersection of SBD and hepatocellular carcinoma tar-gets,which was imported into the STRING platform to construct protein-protein interaction(PPI)network and screen the core targets.Cytoscape was used to construct"Sancao Baogan Decoction-active components-potentialtargets"and"key targets-active components"interactions networks,and screen the main components.The geneontology(GO)and Kyoto encyclopedia of genes and genomes(KEGG)pathways involved in the targets were analyzed by Metascape database.Molecular docking to validate the interaction between active components and targets.Western blot experiments was carried out to confirm the core targets of San-cao Baogan Decoction on liver cancer cells.The results showed that the four main active ingredients of SBD were luteolin,ellagic acid,kaempferol,and quercetin;SBD could exert its anti-hepatocellular carcinoma effects through multiple components,multiple targets,and multiple pathways,among which AKT1 and MAPK3 were important targets for inhibiting hepatocellular carcinoma.